Storys zum Thema Medizin, Gesundheit

Sintetica

Sintetica establishes US entity

Mendrisio, Switzerland (ots/PRNewswire) - Sintetica, a Swiss pharmaceutical company headquartered in Mendrisio specializing in injectables in the field of pain therapy, has taken another important and significant step in its 100-year growth strategy. On July 14, 2022 Sintetica established its subsidiary Sintetica US, headquartered in Princeton, New Jersey, headed by leading pharma expert Frank Mullery (President-Sintetica US). Frank Mullery brings with him more than 20 years ...

Menarini-Silicon Biosystems

Menarini Silicon Biosystems's CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination

Huntingdon Valley, Pa. (ots/PRNewswire) - These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 Circulating Tumor Cell (CTC-HER2) assays, to monitor disease status in patients with life-threatening illnesses. Menarini ...

Pharming Group N.V.

Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib

Leiden, Netherlands (ots/PRNewswire) - Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency This submission follows the grant of accelerated assessment allowing an expedited review for leniolisib from a standard 210 days ...

Evonik Industries AG

Evonik and Phathom Pharmaceuticals partner to produce novel acid-blocker vonoprazan

Essen, Germany (ots/PRNewswire) - - Evonik to produce commercial quantities of the drug substance vonoprazan for use in VOQUEZNA™ TRIPLE PAK™ and DUAL PAK™, and other products containing vonoprazan - Supply security through production at sites in Europe and North America - Agreement strengthens Evonik's track record as leading contract development and ...

Synapse Medicine

Synapse Medicine Initiates Multi-Site Implementation Study with Leading U.S Hospitals

New York (ots/PRNewswire) - - Synapse Medicine clinical decision support technology analyzes drug-related risks based on each patient's clinical characteristics and will be studied for its impact on inpatient pharmacist efficacy and efficiency. - The Synapse Medicine medication reconciliation tool will be deployed through an integration with the hospitals' current EPIC ...

Servier

Servier unveils its 2030 ambition and reveals a new visual identity

Paris (ots/PRNewswire) - - A new ambition by 2030 to accelerate its transformation dynamic - A visual identity, a marker of the successful transformation of the Group, its ambitions and its renewal Servier today unveils its 2030 ambition as well as a new visual identity that reflects the transformation undertaken by the Group, bringing visible results. The Group intends to accelerate its transformation dynamics in order ...

Debiopharm International SA

DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY

Lausanne, Switzerland (ots) - Debiopharm awards the winning scientists for the JCA (Japanese Cancer Association) Award for innovative, disruptive, and translational oncology research Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of JCA Mauvernay ...

News Direct

Landmark Global Review of the Engineering Response to Covid-19 Calls for Action to Ensure Future Pandemic Resilience

London, England (ots) - --News Direct-- - Engineering X review of pandemic preparedness identifies key vulnerabilities - Senior leaders endorse the need for comprehensive action by policymakers, business and academic leaders worldwide Systemic barriers—including a lack of collaboration mechanisms, insufficient ...

PHARMANOVIA

PHARMANOVIA ENTERS EXCLUSIVE LICENSING COLLABORATION FOR DIAZEPAM BUCCAL FILM

London (ots/PRNewswire) - - PHARMANOVIA EXCLUSIVELY LICENCES RIGHTS FOR A NOVEL WAY OF TREATING ACUTE EPILEPSY SEIZURE CLUSTERS IN EUROPE, MIDDLE EAST AND NORTH AFRICA - PATENTED BUCCAL FILM TECHNOLOGY HAS THE POTENTIAL TO IMPROVE THE EASE OF ADMINISTRATION FOR CAREGIVERS, PATIENTS AND HCPs Pharmanovia, the lifecycle management company, has today announced that it has ...

Scientific Group

AS&K Group rebrands as Scientific Group / Move reflects new company vision and brings full-service offering under a unified structure

London, UK (ots) - Leading independent Medical Communications company, AS&K Group, has undergone a rebrand, changing its name to Scientific Group. The move comes a year after the Group celebrated its 25th anniversary and acts to bring its three entities - AS&K Communications, The Corpus and Remedica Communications - ...

Debiopharm International SA

BIG IMPACT, SMALL PACKAGE: DEBIOPHARM LAUNCHES A WAZOKU OPEN-INNOVATION CHALLENGE FOR SMALL ANTIBODY DRUG CONJUGATE TECHNOLOGY

Lausanne, Switzerland (ots) - · Currently approved Antibody-Drug Conjugates (ADCs) are large molecules (150 kDa) composed of an antibody, a cytotoxic payload, and a linker connecting the two precedent elements · Debiopharm has launched an ADC Innovation Challenge to a pool of international “problem Solvers” ...

Guerbet

Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)

Villepinte, France (ots/PRNewswire) - - FDA approval of Elucirem™ (NDA 216986) was granted after priority review, a designation assigned to applications for drugs that provide significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions compared to available therapies. - In the approved indications, a ...

ZENTIVA Pharma GmbH

The fourth ORBIS School enhancing international collaboration on pharmaceutical innovations was held in Prague

Prague (ots/PRNewswire) - Between 7th and 9th September, the fourth ORBIS School was held in Prague. The event was co-hosted by Zentiva in close collaboration with the German company Physiolution and the University of Chemistry and Technology in Prague. Many various lectures and workshops were held during these ...

MC2 Therapeutics

MC2 Therapeutics announces initiation of a Phase 2 clinical trial in CKD-aP

Copenhagen, Denmark (ots/PRNewswire) - - Trial based on the recent breakthrough discovery of a novel treatment paradigm for urea associated skin diseases - First patients dosed in Europe in Phase 2 trial assessing the safety and efficacy of MC2-25 Cream in Chronic Kidney Disease-associated Pruritus (CKD-aP) stages 3-5 patients - MC2-25 Cream has the potential to become ...

MC2 Therapeutics

MC2 Therapeutics announces initiation of a Phase 2 clinical trial in CKD-aP

Copenhagen, Denmark (ots/PRNewswire) - - Trial based on the recent breakthrough discovery of a novel treatment paradigm for urea associated skin diseases - First patients dosed in Europe in Phase 2 trial assessing the safety and efficacy of MC2-25 Cream in Chronic Kidney Disease-associated Pruritus (CKD-aP) stages 3-5 patients - MC2-25 Cream has the potential to become ...

Debiopharm International SA

Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence

Lausanne, Switzerland (ots/PRNewswire) - Debiopharm Innovation Fund strategically invests in Whitelab Genomics' mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in the future Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical ...

Debiopharm International SA

Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence

Lausanne (ots) - Debiopharm Innovation Fund strategically invests in Whitelab Genomics' mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in the future Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm ...

Firmenich

Firmenich Strengthens Sustainability Performance in FY2022

Geneva (ots/PRNewswire) - Audited ESG Report 2022 shows accelerated progress toward industry-leading targets for 2025 Firmenich, the world's largest privately-owned fragrance and taste company, today releases its annual Environmental, Social and Governance (ESG) Report, tracking progress toward the group's groundbreaking sustainability targets. Fiscal Year (FY) 2022 ...

FDI World Dental Federation

FDI World Dental Federation launches toolkit on how to make dentistry more sustainable

European Society for Medical Oncology (ESMO)

ESMO 2022 - Great oaks grow from small acorns: oncology is committed to doing its part for sustainability

Paris (ots) - At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a reality in the clinic. - Late-breaking results elucidate ...

Almirall, S.A.

Almirall: Lebrikizumab Dosed Every Four Weeks Maintained Durable Skin Clearance in Phase 3 Monotherapy Atopic Dermatitis Trials

Barcelona, Spain (ots/PRNewswire) - - New, late-breaking data show lebrikizumab responders reported long-lasting results at one year of treatment across measures of improvement in skin clearance, itch and disease extent and severity - Results suggest less frequent, every four week dosing of lebrikizumab provided ...

genOway

SIGMA-ALDRICH AND GENOWAY EXPAND THEIR CRISPR/CAS9 STRATEGIC ALLIANCE

ST. Louis, Mo. and Lyon, France (ots/PRNewswire) - Sigma-Aldrich Co LLC (a subsidiary of Merck KGaA, Darmstadt, Germany), a leading science and technology company and provider of genome editing research tools, and genOway the leading company in the preclinical research model space, today announced a new structure to their 2018 strategic alliance in the CRISPR/Cas9 ...

Debiopharm International SA

ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS

Lausanne, Switzerland (ots) - - International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics - The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly ...

Hovione

Hovione expands drug product offering with a new manufacturing line dedicated to Continuous Tableting

Lisbon, Portugal (ots/PRNewswire) - Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal. In addition, to ...